The files above contain the model code used in Callender and colleagues' paper, 'Risk-Tailored Screening for Prostate Cancer: A Benefit-Harm and Cost-Effectiveness Analysis'.

The code is made freely available under an MIT licence; however, if you do use, modify, or derive code from it, please cite our code. 
